Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone

Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine

(2012) Angela Corpolongo et al.   MALARIA JOURNAL

Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy

(2011) Marie-Hélène Odièvre et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials

(2011) Nick Carter et al.   MALARIA JOURNAL

A ghostly presence-G6PD deficiency

(2010) Barbara J. Bain   AMERICAN JOURNAL OF HEMATOLOGY

Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding

(2010) Luciana Bordin et al.   BRITISH JOURNAL OF PHARMACOLOGY

Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

(2010) Ilan Youngster et al.   DRUG SAFETY

The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

(2010) Lucio Luzzatto   LANCET

Chlorproguanil–Dapsone–Artesunate versus Chlorproguanil–Dapsone: A Randomized, Double-Blind, Phase III Trial in African Children, Adolescents, and Adults with Uncomplicated Plasmodium falciparum Malaria

(2009) Alfred B. Tiono et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis

(2009) Ella T. Nkhoma et al.   BLOOD CELLS MOLECULES AND DISEASES

Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility

(2009) Taane G Clark et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Discovery, mechanisms of action and combination therapy of artemisinin

(2009) Liwang Cui et al.   Expert Review of Anti-Infective Therapy

Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria

(2009) Zul Premji et al.   PLoS One